AU2011249406B2 - Stem cell bank for personalized medicine - Google Patents

Stem cell bank for personalized medicine Download PDF

Info

Publication number
AU2011249406B2
AU2011249406B2 AU2011249406A AU2011249406A AU2011249406B2 AU 2011249406 B2 AU2011249406 B2 AU 2011249406B2 AU 2011249406 A AU2011249406 A AU 2011249406A AU 2011249406 A AU2011249406 A AU 2011249406A AU 2011249406 B2 AU2011249406 B2 AU 2011249406B2
Authority
AU
Australia
Prior art keywords
stem cells
cells
stem
stem cell
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011249406A
Other languages
English (en)
Other versions
AU2011249406A1 (en
Inventor
Ehud Marom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stem Cell Medicine Ltd
Original Assignee
Stem Cell Medicine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stem Cell Medicine Ltd filed Critical Stem Cell Medicine Ltd
Publication of AU2011249406A1 publication Critical patent/AU2011249406A1/en
Application granted granted Critical
Publication of AU2011249406B2 publication Critical patent/AU2011249406B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Library & Information Science (AREA)
AU2011249406A 2010-05-06 2011-05-05 Stem cell bank for personalized medicine Ceased AU2011249406B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33184210P 2010-05-06 2010-05-06
US61/331,842 2010-05-06
US201161429773P 2011-01-05 2011-01-05
US61/429,773 2011-01-05
PCT/IL2011/000362 WO2011138786A2 (en) 2010-05-06 2011-05-05 Stem cell bank for personalized medicine

Publications (2)

Publication Number Publication Date
AU2011249406A1 AU2011249406A1 (en) 2012-11-29
AU2011249406B2 true AU2011249406B2 (en) 2015-05-14

Family

ID=44904175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011249406A Ceased AU2011249406B2 (en) 2010-05-06 2011-05-05 Stem cell bank for personalized medicine

Country Status (7)

Country Link
US (2) US20130052169A1 (enExample)
EP (1) EP2566955A4 (enExample)
JP (3) JP2013528368A (enExample)
CN (1) CN103025865A (enExample)
AU (1) AU2011249406B2 (enExample)
CA (1) CA2798571A1 (enExample)
WO (1) WO2011138786A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
CN104902909A (zh) 2012-06-26 2015-09-09 拉斯提地产控股企业有限公司 用于降低头痛的频率和/或严重性的组合物及方法
CA2899246C (en) 2013-03-13 2022-12-06 Allosource Fascia fibrous compositions and methods for their use and manufacture
KR102312720B1 (ko) 2013-03-15 2021-10-13 알로소스 연조직 회복 및 재생을 위한 세포 재배치된 콜라겐 매트릭스
US10738323B2 (en) 2013-07-12 2020-08-11 Cedars-Sinai Medical Center Generation of induced pluripotent stem cells from normal human mammary epithelial cells
WO2015030149A1 (ja) * 2013-08-29 2015-03-05 国立大学法人鳥取大学 細胞のアンチエイジングに関連する生体分子群
US9795707B2 (en) 2013-12-06 2017-10-24 Allosource Methods of drying sheets of donor-provided human birth tissue
US20150216539A1 (en) * 2014-02-06 2015-08-06 Stryker European Holdings I, Llc Bone marrow harvesting and storage
US9867853B2 (en) 2014-05-30 2018-01-16 International Cell Technologies Inc. Method of providing cellular based immune enhancement for restoring immunity and preventing age related diseases
US10264976B2 (en) 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging
WO2016154310A1 (en) 2015-03-24 2016-09-29 Stryker European Holdings I, Llc Bone marrow harvesting device and storage methods
JP7244991B2 (ja) * 2015-11-24 2023-03-23 ロート製薬株式会社 脂肪組織由来間質細胞を含む肝疾患治療剤およびその製造方法
GB201600597D0 (en) * 2016-01-12 2016-02-24 Occhipinti Luigi G And Pluchino Stefano And Cambridge Innovation Technologies Consulting Ltd Banking of stem cells and business methods related to the same
US11572545B2 (en) 2016-06-16 2023-02-07 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
US10221395B2 (en) 2016-06-16 2019-03-05 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
WO2018026576A1 (en) * 2016-08-04 2018-02-08 Good Start Genetics, Inc. Genomic analysis of cord blood
WO2018027116A1 (en) * 2016-08-05 2018-02-08 Jay Yadav Plasma banking to mitigate aging
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
WO2018170046A1 (en) * 2017-03-14 2018-09-20 Orig3N, Inc. Hla-indexed repository of ipscs and ipsc-derived stem cells, and related systems and methods
TW201912785A (zh) * 2017-09-01 2019-04-01 美商歐瑞３恩公司 使用ｉＰＳＣ之ＨＬＡ－匹配庫之同種異體ＣＡＲ－Ｔ平台及相關的組合物、系統及方法
AU2018324301A1 (en) * 2017-09-01 2020-04-16 Orig3N, Inc. I-PSC derived secretome compositions, and related systems and methods
KR20200051714A (ko) * 2017-09-06 2020-05-13 난트 홀딩스 아이피, 엘엘씨 Hla 조직 매칭 및 그에 관한 방법(hla tissue matching and methods therefor)
US20190338244A1 (en) * 2017-11-30 2019-11-07 New York Medical College Multipotent adult stem cells: characterization and use
CN112955963B (zh) * 2018-12-21 2025-02-11 爱平世股份有限公司 健康风险信息管理装置、计算机及记录介质
CN114242191A (zh) * 2021-10-29 2022-03-25 南京国青血液净化科技有限公司 干细胞自助配型方法及配型装置

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040091936A1 (en) * 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
US20040258673A1 (en) * 2003-04-03 2004-12-23 Hirose Thomas Gordon Elective collection and banking of autologous peripheral blood stem cells
US20050276792A1 (en) * 2004-03-26 2005-12-15 Kaminski Joseph K Systems and methods for providing a stem cell bank
US20070292910A1 (en) * 2005-12-29 2007-12-20 Mohammad Heidaran Co-culture of placental stem cells and stem cells from a second source

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1942739B1 (en) * 2005-10-18 2010-12-08 National Jewish Health Conditionally immortalized long-term adult stem cells and methods of making and using such cells
CA2629283A1 (en) * 2005-11-14 2007-05-24 The New England Medical Center Hospitals, Inc. Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US20080038231A1 (en) * 2006-06-15 2008-02-14 Rodgerson Denis O Processing procedure for peripheral blood stem cells
US20090016997A1 (en) * 2007-04-11 2009-01-15 Hathaway Alecia A Autologous/allogeneic human DNA grafting, anti-and reverse aging stem cell, and bone marrow compositions/methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040091936A1 (en) * 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
US20040258673A1 (en) * 2003-04-03 2004-12-23 Hirose Thomas Gordon Elective collection and banking of autologous peripheral blood stem cells
US20050276792A1 (en) * 2004-03-26 2005-12-15 Kaminski Joseph K Systems and methods for providing a stem cell bank
US20070292910A1 (en) * 2005-12-29 2007-12-20 Mohammad Heidaran Co-culture of placental stem cells and stem cells from a second source

Also Published As

Publication number Publication date
EP2566955A2 (en) 2013-03-13
AU2011249406A1 (en) 2012-11-29
CA2798571A1 (en) 2011-11-10
US20130052169A1 (en) 2013-02-28
CN103025865A (zh) 2013-04-03
JP2016189783A (ja) 2016-11-10
US20160122709A1 (en) 2016-05-05
JP2013528368A (ja) 2013-07-11
JP2018121650A (ja) 2018-08-09
WO2011138786A3 (en) 2012-04-12
WO2011138786A2 (en) 2011-11-10
EP2566955A4 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
AU2011249406B2 (en) Stem cell bank for personalized medicine
Dominici et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Forraz et al. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine
Lako et al. Hair follicle dermal cells repopulate the mouse haematopoietic system
KR100871984B1 (ko) 태반 조직 유래 다능성 줄기세포 및 이를 함유하는세포치료제
TWI686202B (zh) 體幹細胞
Mauro et al. Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells
US20090280093A1 (en) Compositions and populations of cells obtained from the umbilical cord and methods of producing the same
US20080226612A1 (en) Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof
TW200523368A (en) Multipotent placental stem cell and methods thereof
Matsuda et al. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development
US20060030039A1 (en) Placental stem cell and methods thereof
WO2003080822A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
Fink et al. Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum
KR20180115657A (ko) 개과동물 양막-유래 다분화능 줄기세포
US20160158292A1 (en) Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof
Cetrulo et al. Perinatal stem cells
Jain et al. Stem cells research prospects towards precision medicine.
Klingenstein et al. State-of-the-Art: Somatic Cell Sources Used for the Generation of Human Induced Pluripotent Stem Cells
Azeem et al. Umbilical cord stem cells: A review
Law et al. Scientific Basis for Stem Cell Therapy
RU2774350C2 (ru) Способ получения биомедицинского клеточного продукта для лечения онкологических, нейродегенеративных и аутоиммунных заболеваний
Siddiqui et al. Stem Cells
Srinivas et al. AN ESSENTIAL PARAMETERS OF IMPORTANCE OF STEM CELLS IN MODERN MEDICINE INCLUDE EXAMPLES OF STEM CELLS THERAPIES IN MEDICINE, NEURO DEGENERATIVE DISEASES AND PHARMACOLOGICAL TESTING
Fergany Faculty of Biotechnology Research Project RS400 (Pre-Cryopreservation Umbilical Cord Blood quality: The significance of Gestational age and

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired